Resumen: Protein amyloid aggregation has been associated with more than 50 human disorders, including the most common neurodegenerative disorders Alzheimer’s and Parkinson’s disease. Interfering with this process is considered as a promising therapeutic strategy for these diseases. Our understanding of the process of amyloid aggregation and its role in disease has typically been limited by the use of ensemble-based biochemical and biophysical techniques, owing to the intrinsic heterogeneity and complexity of the process. Single-molecule techniques, and particularly diffusion-based single-molecule fluorescence approaches, have been instrumental to obtain meaningful information on the dynamic nature of the fibril-forming process, as well as the characterisation of the heterogeneity of the amyloid aggregates and the understanding of the molecular basis of inhibition of a number of molecules with therapeutic interest. In this article, we reviewed some recent contributions on the characterisation of the amyloid aggregation process, the identification of distinct structural groups of aggregates in homotypic or heterotypic aggregation, as well as on the study of the interaction of amyloid aggregates with other molecules, allowing the estimation of the binding sites, affinities, and avidities as examples of the type of relevant information we can obtain about these processes using these techniques. Idioma: Inglés DOI: 10.3390/biophysica2040043 Año: 2022 Publicado en: Biophysica 2, 4 (2022), 506-524 ISSN: 2673-4125 Financiación: info:eu-repo/grantAgreement/ES/DGA/B49-20D Financiación: info:eu-repo/grantAgreement/ES/DGA/LMP175_21 Financiación: info:eu-repo/grantAgreement/ES/FEDER/Una manera de hacer Europa Financiación: info:eu-repo/grantAgreement/ES/MICINN-AEI/PGC2018-096335-B100 Financiación: info:eu-repo/grantAgreement/ES/MCIN/AEI/10.13039/501100011033 Tipo y forma: Revisión (Versión definitiva) Área (Departamento): Área Bioquímica y Biolog.Mole. (Dpto. Bioq.Biolog.Mol. Celular)